Submitted for Publication: September 10, 2011; final revision received December 14, 2011; accepted December 23, 2011.
Author Contributions: All authors had full access to all the data in the study. Dr Kessler takes responsibility for the integrity of the data and the accuracy of the data analysis.
Conflict of Interest Disclosures: Dr Kessler has been a consultant for AstraZeneca, Analysis Group Inc, Bristol-Myers Squibb, Cerner-Galt Associates, Eli Lilly & Company, GlaxoSmithKline Inc, HealthCore Inc, Health Dialog, Integrated Benefits Institute, John Snow Inc, Kaiser Permanente, Matria Inc, Mensante, Merck & Co Inc, Ortho-McNeil Janssen Scientific Affairs, Pfizer Inc, Primary Care Network, Research Triangle Institute, sanofi-aventis Groupe, Shire US Inc, SRA International Inc, Takeda Global Research & Development, Transcept Pharmaceuticals Inc, and Wyeth-Ayerst; has served on advisory boards for Appliance Computing II, Eli Lilly & Company, Mindsite, Ortho-McNeil Janssen Scientific Affairs, Plus One Health Management, and Wyeth-Ayerst; and has received research support for his epidemiological studies from Analysis Group Inc, Bristol-Myers Squibb, Eli Lilly & Company, EPI-Q, GlaxoSmithKline Inc, Johnson & Johnson Pharmaceuticals, Ortho-McNeil Janssen Scientific Affairs, Pfizer Inc, sanofi-aventis Groupe, and Shire US Inc.
Funding/Support: Preparation of this article was supported by grants K01-MH092526 (Dr McLaughlin) and K01-MH085710 (Dr Greif Green) from the National Institute of Mental Health (NIMH). The National Comorbidity Survey Replication Adolescent Supplement (NCS-A) is supported by grants U01-MH60220 and R01-MH66627 from the NIMH, with supplemental support from the National Institute on Drug Abuse, the Substance Abuse and Mental Health Services Administration, grant 044780 from the Robert Wood Johnson Foundation, and the John W. Alden Trust. The World Mental Health (WMH) Data Coordination Centres have been supported by grants R01-MH070884, R13-MH066849, R01-MH069864, and R01-MH077883 from the NIMH, grant R01-DA016558 from the National Institute on Drug Abuse, grant R03-TW006481 from the Fogarty International Center of the National Institutes of Health, the John D. and Catherine T. MacArthur Foundation, Pfizer Inc, and the Pan American Health Organization. The WMH Data Coordination Centres have also received unrestricted educational grants from AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Company, GlaxoSmithKline, Ortho-McNeil Janssen Scientific Affairs, Pfizer Inc, sanofi-aventis Groupe, and Wyeth-Ayerst. A complete list of WMH publications can be found at http://www.hcp.med.harvard.edu/wmh. A complete list of NCS-A publications can be found at http://www.hcp.med.harvard.edu/ncs. Send correspondence to email@example.com. The NCS-A is carried out in conjunction with the World Health Organization WMH Survey Initiative.
Role of the Sponsors: The sponsors had no role in the design or conduct of the study; the collection, management, analysis, or interpretation of the data; or the preparation, review, or approval of the manuscript.
Disclaimer: The views and opinions expressed in this study are those of the authors and should not be construed to represent the views of any of the sponsoring organizations or agencies or the US government.
Additional Contributions: The staff of the WMH Data Collection and Data Analysis Coordination Centres assisted with instrumentation, fieldwork, and consultation on data analysis.